Debut Plus

2,816.9

+110.42 +4.08%

17 Jul 2026

NSE Listed

Kwality Pharmaceuticals Limited (KPL)

Volume: 31,108Avg Vol 1W: 19,348.6Avg Vol 1M: 32,219.6552W Range:1,5612,890.3
Market Cap₹2,808 Cr
Current Price₹2,816.9
Previous Close₹2,706.48
High / Low (52w)₹2,890.3 / ₹1,561
Volume31,108
Avg Vol (1W)19,348.6
Avg Vol (1M)32,219.65
Stock P/E41.32
Book Value₹319.46
Dividend Yield0%
ROE20.31%
ROA11.37%
Revenue (TTM)₹372 Cr
Revenue Growth
Profit Margin13.39%
Total Debt
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹24.39
P/B8.5
Debt / Equity0.43
50 DMA₹2,386.85
200 DMA₹2,209.42
Day change+4.08%
Price Chart
2,816.9 69.43% · 1Y
281715804.6L
2026-04-20
2026-07-15

20-day avg volume: 32K shares

Pros
  • Healthy return on equity of 20.3%.
  • Company is almost debt-free.
Cons
  • Revenue fell 17% YoY.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹80 Cr₹90 Cr₹84 Cr₹116 Cr₹111 Cr₹111 Cr₹123 Cr₹157 Cr
EBITDA₹14 Cr₹15 Cr₹14 Cr₹22 Cr₹20 Cr₹21 Cr₹26 Cr₹35 Cr
Net Profit₹8 Cr₹8 Cr₹9 Cr₹14 Cr₹12 Cr₹14 Cr₹16 Cr₹25 Cr
EPS
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹138 Cr₹167 Cr₹143 Cr₹264 Cr₹460 Cr₹254 Cr₹309 Cr₹372 Cr
EBITDA₹9 Cr₹13 Cr₹13 Cr₹24 Cr₹164 Cr₹48 Cr₹49 Cr₹64 Cr
Net Profit₹5 Cr₹8 Cr₹8 Cr₹15 Cr₹120 Cr₹19 Cr₹24 Cr₹40 Cr
EPS4.387.288.0214.6115.1218.1622.7638.36
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹96 Cr₹105 Cr₹133 Cr₹166 Cr₹341 Cr₹354 Cr₹394 Cr₹447 Cr
Total Liabilities₹67 Cr₹69 Cr₹88 Cr₹106 Cr₹161 Cr₹155 Cr₹172 Cr₹185 Cr
Equity₹29 Cr₹36 Cr₹45 Cr₹60 Cr₹180 Cr₹199 Cr₹223 Cr₹262 Cr
Total Debt
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹2 Cr₹17 Cr₹9 Cr₹33 Cr₹102 Cr₹48 Cr₹44 Cr₹69 Cr
Investing₹-6 Cr₹-12 Cr₹-18 Cr₹-23 Cr₹-63 Cr₹-48 Cr₹-26 Cr₹-29 Cr
Financing₹5 Cr₹-2 Cr₹12 Cr₹1 Cr₹6 Cr₹1 Cr₹-17 Cr₹-14 Cr
Free Cash Flow₹2 Cr₹17 Cr₹9 Cr₹33 Cr₹102 Cr₹48 Cr₹44 Cr₹69 Cr
Shareholding
Promoter 54.87% Institutions 3.15% Public 41.98%
Efficiency & Working Capital
ROCE21.5%
Interest Coverage6.5
Dividend Payout
Debtor Days152 d
Inventory Days82 d
Payable Days55 d
Cash Conversion Cycle179 d
Working Capital Days234 d
Shareholding Details

As of 2026-03-31

Promoter54.9%
FII2.8%
DII0.4%
Institutions3.1%
Public42%
Promoter Pledge0%
No. of Shareholders10,555
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters54.7%54.8%54.8%54.8%54.8%54.8%54.8%54.8%54.8%54.8%54.8%54.9%
FIIs0%0%0%0%0%0%0%0%0%0%0.5%2.8%
DIIs0%0%0%0%0%0%0%0.3%0.3%0.3%0.3%0.4%
Public45.3%45.2%45.2%45.2%45.2%45.2%45.1%44.9%44.8%44.8%44.3%42%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders6,9436,2915,7865,6955,2737,4878,9479,42010,11511,59510,70910,555
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Ramesh AroraShareholding of Promoter and Promoter Group26%27,00,632
Ajay AroraShareholding of Promoter and Promoter Group13.6%14,11,579
Aditya AroraShareholding of Promoter and Promoter Group12%12,41,039
Deepak BansalPublic Shareholding9.2%9,58,746
Manohar DevabhaktuniPublic Shareholding5%5,16,735
Ark Global Emerging Companies, LpPublic Shareholding2.1%2,18,896
Kadayam Ramnathan BharatPublic Shareholding2%2,05,000
Dheeraj Kumar LohiaPublic Shareholding1.9%1,93,358
Jani Bhasha ShaikPublic Shareholding1.5%1,50,000
Anju AroraShareholding of Promoter and Promoter Group1.3%1,35,634
Onkar SinghPublic Shareholding1.1%1,13,200
Geeta AroraShareholding of Promoter and Promoter Group1.1%1,11,500
Jugal Kishore HufShareholding of Promoter and Promoter Group0.9%92,350
Aarti BajajShareholding of Promoter and Promoter Group0%125
Sachin SethShareholding of Promoter and Promoter Group0%210
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Ajay Arora00%2026-03-31
Ramesh Arora00%2026-03-31
Jugal Kishore Huf00%2026-03-31
Anju Arora00%2026-03-31
Geeta Arora00%2026-03-31
Aarti Bajaj00%2026-03-31
Sachin Seth00%2026-03-31
Aditya Arora00%2026-03-31
Ark Global Emerging Companies, Lp00%2026-03-31
Kadayam Ramnathan Bharat00%2026-03-31
Deepak Bansal00%2026-03-31
Onkar Singh00%2026-03-31
Board of Directors
NameDesignationYear
Ramesh AroraExecutive Director & MD2025
Ajay AroraE D & Wholetime Director2025
Aditya AroraExecutive Director / Whole Time Director / CFO2025
Geeta AroraE D & Wholetime Director2025
Anju AroraE D & Wholetime Director2025
Kartik KapurIndependent Non Exe. Director2025
Prashanth VellankiIndependent Non Exe. Director2025
Vinod Kumar SharmaIndependent Non Exe. Director2025
Gurpreet KaurCompany Sec. & Compli. Officer2025
Bhavesh MahajanIndependent Non Exe. Director2025
Preet Mohinder S BediIndependent Non Exe. Director2025
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹0 Cr
Segments — Geography
RegionRevenueShare
Export₹195 Cr52.8%
Domestic₹175 Cr47.2%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10161010
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025500308
2025000000
2025500308
Insider / Designated-Person Trades

29 recent disclosure(s)

Aastha SethAcquisition · 1,000
RAMESH KUMARAcquisition · 1,948
AJAY KUMAR ARORAAcquisition · 941
ADITYA ARORAAcquisition · 948
ADITYA ARORAAcquisition · 4,919
ADITYA ARORAAcquisition · 3,200
Substantial Acquisitions (SAST)

6 disclosure(s)

Market16/02/2024 · 1,200
Market15/02/2024 · 4,919
Market30/06/2023 · 1,04,000
-27/06/2023 · 5,18,810
Market24/05/2023 - 08/06/2023 · 3,02,000
NULL15/12/2021 · 25,620
Company Information
Incorporated1983
AuditorVijay Mehra & Co
Investor Email[email protected]
🌐 www.kwalitypharma.com

📍 Village Nagkalan, Majitha Road, Amritsar, Punjab, 143601

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search